Tumors/Animal ±S.E. | |||||
Retinoids | N | Week 15 | Tumor Size (mm2) | ||
DMBA/TPA | 15 | 9.2 ± 6.8 | 313.5 | ||
t-Retinoic acid | 8 | 1.0 ± 1.0 | 14.5 | ||
N-(Oxoestra-1,3,5(10)-trien-yl-retinamide | 8 | 6.4 ± 4.0 | 128 | ||
4-Oxo-3(2-propenyl)retinoic acid | 7 | 4.3 ± 4.3 | 61.5 | ||
4-Oxo-3-(2-propenyl)retinyl methyl ester | 7 | 3.9 ± 3.2 | 54.3 | ||
4-Oxo-3-(2-propnyl)retinoic acid | 8 | 5.9 ± 5.2 | 126 | ||
3-Ethyl-4-oxoretinyl methyl ester | 8 | 6.0 ± 5.8 | 276 | ||
3,3-Dimethyl4-oxoretinyl methyl ester | 7 | 2.0 ± 4.0 | 40 | ||
3-Ethyl 4-oxoretinyl methyl ester | 8 | 7.1 ± 5.8 | 94 | ||
4-Oxo-3-(2-propenyl)retinyl methyl ester | 7 | 3.7 ± 3.5 | 72.5 | ||
TMMP analog of retinol | 7 | 13.7 ± 10.2 | 504.5 | ||
TMMP analog of retinol | Log of retinyl methyl ether | 8 | 11.9 ± 7.1 | 228 | |
(E)-4[-2-(5,6,7,8-Tetra hydro-8,8-dimethyl |
| ||||
2-Naphthyl)propenyl]phenylmethanol | 8 | 1.0 ± 1.3 | 4 | ||
(E)-4[-2-(5,6,7,8-Tetra hydro-8,8-dimethyl |
| ||||
2-Naphthylpropenyl]benzoic acid | 7 | 2 | |||
(2E,4E,6E)-3-Methyl-7(5,6,7,8-tetrahydro[- | 7 | 1.7 ± 2.0 | 12 | ||
8,8-Dimethyl)2-naphthyl)2,4,6-oxoretinoic acid |
| ||||
Acetone | 15 | 0 | |||
Acetone/TPA | 15 | 0 | |||
DMBA/Acetone | 7 | 0 | |||